Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00.
Ultracentrifugation with 10 - 40 % sucrose gradient.
STE, 0.09 % sodium azide (NaN₃) and 0.005 % thimerosal.
Thimerosal and beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.
Purity > 90 %
Tested with anti-influenza B monoclonal antibodies (Cat. # 3IF18) in ELISA.
Serological studies of influenza B virus, immunogen for antibody production.
-20 °C (-15 … -30 °C allowed)
This product is sold for research or further manufacturing use only. Standard Laboratory Practices should be followed when handling this material.
Product contains thimerosal and sodium azide as a preservative. Although the amounts are very small appropriate care must be taken when handling this product.
(Catalogue number and MAb: 8IN75-3)